Image: PD Human eyesight with glaucoma
1. Various concentrations of Rho kinase inhibitor K-115 decreased IOP after administration compared to placebo (p<0.05).
2. The only significant side effect was conjunctival hyperemia, which was painless and resolved within 6 hours.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Rho kinase inhibitors are a promising new...